BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, January 2, 2026
See today's BioWorld
Home
» Other news to note for Jan. 8, 2024
To read the full story,
subscribe
or
sign in
.
Other news to note for Jan. 8, 2024
Jan. 8, 2024
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aobiome, Ascendis, Base4, Biocytogen, BMS, Calypso, Cipla, Debiopharm, Denali, Essential, Evotec, Exelixis, Flagship, Glykos, ICER, Iktos, Immunome, Inimmune, Intrommune, J&J, Kemwell, Manipal Education & Medical, Maruho, Medison, Molecular Partners, Nerviano, Novartis, Orano, Orion, Radiance, Regeneron, Sanreno, Servier, Simcha, Specialised, Sunrock, Teva, Zentalis.
BioWorld
Briefs
Other news to note